-transparent.png){kind=logo}
The effects of the ACTH 4-9 analog (Org 2766) and the COOH-terminal tripeptide of Org 2766 (Phe-D-Lys-Phe; PDLP) on retrieval of one-trial learning passive avoidance behavior were compared with those of beta-endorphin, [Met5]-enkephalin, [D-Ala2,Met5]-enkephalin, des-Tyr1-[Met5]-enkephalin and des-enkephalin-gamma-endorphin (DE gamma E). Amounts of intracerebroventricularly administered Org 2766, PDLP, [Met5]-enkephalin, [D-Ala2,Met5]-enkephalin and DE gamma E, which induced a comparable attenuation of passive avoidance behavior were determined. Pretreatment with the opiate antagonist naltrexone prevented the attenuating effect of these peptides on passive avoidance behavior except that of DE gamma E. The attenuating effect of Org 2766 and of [Met5]-enkephalin was reversed to facilitation of passive avoidance behavior in the presence of naltrexone. Subcutaneous treatment with Org 2766 and [D-Phe7]-ACTH 4-10 decreased electrical self-stimulation behavior elicited from the medial septal area. Naltrexone prevented the inhibitory effect of Org 2766 on this behavior, but not that of [D-Phe7]-ACTH 4-10. Although the attenuating effect of PDLP on passive avoidance behavior was not reduced by pretreatment with [Met5]-enkephalin- or beta-endorphin-antiserum, and PDLP induced neither analgesia nor excessive grooming, the data suggest that the inhibitory effect of Org 2766 and PDLP on passive avoidance behavior and electrical self-stimulation are mediated by endorphin systems in the brain.
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
March 1993,
European journal of pharmacology,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
January 1989,
Psychopharmacology bulletin,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
January 1976,
Pharmacology, biochemistry, and behavior,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
July 1979,
Physiology & behavior,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
July 1982,
European journal of pharmacology,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
January 1982,
Peptides,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
June 1979,
Pharmacology, biochemistry, and behavior,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
January 1988,
Peptides,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
September 1994,
International journal of oncology,
M Fekete, and
F Drago, and
J M Van Ree, and
B Bohus, and
V M Wiegant, and
D De Wied
January 1991,
Life sciences,
